Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Belgium Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20042
20054
20062
20073
20081
20104
20111
20122
20133
20142
20151
20161
20171
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated7
Recruiting3
Active, not recruiting1
No longer available1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Bristol-Myers Squibb7
Ariad Pharmaceuticals3
Pfizer3
Ascentage Pharma Group Inc.1
Commissie Voor Klinisch Toegepast Onderzoek1
Enliven Therapeutics1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Incyte Biosciences Benelux1
Poitiers University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive32
Leukemia6
Bone Marrow Diseases5
Leukemia, Myeloid5
Leukemia, Myeloid, Chronic-Phase5
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hematologic Diseases3
Myeloproliferative Disorders3
Neoplasms by Histologic Type3
Hematologic Neoplasms2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.